Anesthesia for muscle biopsy to test susceptibility to malignant hyperthermia

Abstract Introduction Malignant hyperthermia is an autosomal dominant pharmacogenetic disorder, characterized by hypermetabolic crisis triggered by halogenated anesthetics and/or succinylcholine. The standard method for diagnosing malignant hyperthermia susceptibility is the in vitro muscle contracture test in response to halothane-caffeine, which requires muscle biopsy under anesthesia. We describe a series of anesthetic procedures without triggering agents in malignant hyperthermia, comparing peripheral nerve block and subarachnoid anesthesia. Method We assessed the anesthetic record charts of 69 patients suspected of malignant hyperthermia susceptibility who underwent muscle biopsy for in vitro muscle contracture in the period of 7 years. Demographic data, indication for malignant hyperthermia investigation, in vitro muscle contracture test results, and surgery/anesthesia/recovery data were analyzed. Results Sample with 34 ± 13.7 years, 60.9% women, 65.2% of in vitro muscle contracture test positive. Techniques used: peripheral nerve blocks — lateral femoral and femoral cutaneous, latency 65 ± 41 min — (47.8%); subarachnoid anesthesia (49.3%), and total venous anesthesia (1.4%). There was 39.4% failure of peripheral nerve block and 11.8% of subarachnoid anesthesia. Adverse events (8.7%) occurred only with subarachnoid blockade (bradycardia, nausea, and transient neurological syndrome). All patients remained in the post-anesthesia care unit until discharge. Age and weight were significantly higher in patients with blockade failure (ROC cut-off point of 23.5 years and 59.5 kg) and blockade failure was more frequent in the presence of increased idiopathic creatine kinase. Conclusion Anesthesia with non-triggering agents has been shown to be safe in patients with malignant hyperthermia susceptibility. Variables such as age, weight, and history of increased idiopathic creatine kinase may be useful in selecting the anesthetic technique for this group of patients.

Saved in:
Bibliographic Details
Main Authors: Silva,Helga Cristina Almeida da, Onari,Elton Shinji, Castro,Isac de, Perez,Marcelo Vaz, Hortensi,Alexandre, Amaral,José Luiz Gomes do
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Anestesiologia 2019
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942019000400002
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-70942019000400002
record_format ojs
spelling oai:scielo:S0034-709420190004000022019-10-08Anesthesia for muscle biopsy to test susceptibility to malignant hyperthermiaSilva,Helga Cristina Almeida daOnari,Elton ShinjiCastro,Isac dePerez,Marcelo VazHortensi,AlexandreAmaral,José Luiz Gomes do Malignant hyperthermia Anesthesia Nerve block Abstract Introduction Malignant hyperthermia is an autosomal dominant pharmacogenetic disorder, characterized by hypermetabolic crisis triggered by halogenated anesthetics and/or succinylcholine. The standard method for diagnosing malignant hyperthermia susceptibility is the in vitro muscle contracture test in response to halothane-caffeine, which requires muscle biopsy under anesthesia. We describe a series of anesthetic procedures without triggering agents in malignant hyperthermia, comparing peripheral nerve block and subarachnoid anesthesia. Method We assessed the anesthetic record charts of 69 patients suspected of malignant hyperthermia susceptibility who underwent muscle biopsy for in vitro muscle contracture in the period of 7 years. Demographic data, indication for malignant hyperthermia investigation, in vitro muscle contracture test results, and surgery/anesthesia/recovery data were analyzed. Results Sample with 34 ± 13.7 years, 60.9% women, 65.2% of in vitro muscle contracture test positive. Techniques used: peripheral nerve blocks — lateral femoral and femoral cutaneous, latency 65 ± 41 min — (47.8%); subarachnoid anesthesia (49.3%), and total venous anesthesia (1.4%). There was 39.4% failure of peripheral nerve block and 11.8% of subarachnoid anesthesia. Adverse events (8.7%) occurred only with subarachnoid blockade (bradycardia, nausea, and transient neurological syndrome). All patients remained in the post-anesthesia care unit until discharge. Age and weight were significantly higher in patients with blockade failure (ROC cut-off point of 23.5 years and 59.5 kg) and blockade failure was more frequent in the presence of increased idiopathic creatine kinase. Conclusion Anesthesia with non-triggering agents has been shown to be safe in patients with malignant hyperthermia susceptibility. Variables such as age, weight, and history of increased idiopathic creatine kinase may be useful in selecting the anesthetic technique for this group of patients.info:eu-repo/semantics/openAccessSociedade Brasileira de AnestesiologiaRevista Brasileira de Anestesiologia v.69 n.4 20192019-08-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942019000400002en10.1016/j.bjane.2019.02.003
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Silva,Helga Cristina Almeida da
Onari,Elton Shinji
Castro,Isac de
Perez,Marcelo Vaz
Hortensi,Alexandre
Amaral,José Luiz Gomes do
spellingShingle Silva,Helga Cristina Almeida da
Onari,Elton Shinji
Castro,Isac de
Perez,Marcelo Vaz
Hortensi,Alexandre
Amaral,José Luiz Gomes do
Anesthesia for muscle biopsy to test susceptibility to malignant hyperthermia
author_facet Silva,Helga Cristina Almeida da
Onari,Elton Shinji
Castro,Isac de
Perez,Marcelo Vaz
Hortensi,Alexandre
Amaral,José Luiz Gomes do
author_sort Silva,Helga Cristina Almeida da
title Anesthesia for muscle biopsy to test susceptibility to malignant hyperthermia
title_short Anesthesia for muscle biopsy to test susceptibility to malignant hyperthermia
title_full Anesthesia for muscle biopsy to test susceptibility to malignant hyperthermia
title_fullStr Anesthesia for muscle biopsy to test susceptibility to malignant hyperthermia
title_full_unstemmed Anesthesia for muscle biopsy to test susceptibility to malignant hyperthermia
title_sort anesthesia for muscle biopsy to test susceptibility to malignant hyperthermia
description Abstract Introduction Malignant hyperthermia is an autosomal dominant pharmacogenetic disorder, characterized by hypermetabolic crisis triggered by halogenated anesthetics and/or succinylcholine. The standard method for diagnosing malignant hyperthermia susceptibility is the in vitro muscle contracture test in response to halothane-caffeine, which requires muscle biopsy under anesthesia. We describe a series of anesthetic procedures without triggering agents in malignant hyperthermia, comparing peripheral nerve block and subarachnoid anesthesia. Method We assessed the anesthetic record charts of 69 patients suspected of malignant hyperthermia susceptibility who underwent muscle biopsy for in vitro muscle contracture in the period of 7 years. Demographic data, indication for malignant hyperthermia investigation, in vitro muscle contracture test results, and surgery/anesthesia/recovery data were analyzed. Results Sample with 34 ± 13.7 years, 60.9% women, 65.2% of in vitro muscle contracture test positive. Techniques used: peripheral nerve blocks — lateral femoral and femoral cutaneous, latency 65 ± 41 min — (47.8%); subarachnoid anesthesia (49.3%), and total venous anesthesia (1.4%). There was 39.4% failure of peripheral nerve block and 11.8% of subarachnoid anesthesia. Adverse events (8.7%) occurred only with subarachnoid blockade (bradycardia, nausea, and transient neurological syndrome). All patients remained in the post-anesthesia care unit until discharge. Age and weight were significantly higher in patients with blockade failure (ROC cut-off point of 23.5 years and 59.5 kg) and blockade failure was more frequent in the presence of increased idiopathic creatine kinase. Conclusion Anesthesia with non-triggering agents has been shown to be safe in patients with malignant hyperthermia susceptibility. Variables such as age, weight, and history of increased idiopathic creatine kinase may be useful in selecting the anesthetic technique for this group of patients.
publisher Sociedade Brasileira de Anestesiologia
publishDate 2019
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942019000400002
work_keys_str_mv AT silvahelgacristinaalmeidada anesthesiaformusclebiopsytotestsusceptibilitytomalignanthyperthermia
AT onarieltonshinji anesthesiaformusclebiopsytotestsusceptibilitytomalignanthyperthermia
AT castroisacde anesthesiaformusclebiopsytotestsusceptibilitytomalignanthyperthermia
AT perezmarcelovaz anesthesiaformusclebiopsytotestsusceptibilitytomalignanthyperthermia
AT hortensialexandre anesthesiaformusclebiopsytotestsusceptibilitytomalignanthyperthermia
AT amaraljoseluizgomesdo anesthesiaformusclebiopsytotestsusceptibilitytomalignanthyperthermia
_version_ 1756376380560375808